13 results
Esophageal Crohn's Disease Management Algorithm

Assess for Active Symptoms and for Stricturing/Fistulizing Disease
Stricturing DX:
 • Bx r/o
Esophageal Crohn's Disease ... Management Algorithm ... Assess for Active ... #Management #Algorithm ... #treatment #IBD
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Pearls: • IDA and active ... NRH & Heme eval. re ... ileal Crohn's/resection ... fatigue despite disease ... #management
The 6 C’s of Primary Sclerosing Cholangitis (PSC)
PSC is a chronic, cholestatic, immune-mediated disease characterized by
ducts, commonly leading ... with persistently active ... management. ... Cholangitis #diagnosis #management ... #summary #Hepatology
Esophageal Variceal Bleeding - Scoping Summary
GENERAL PRINCIPLES OF MANAGEMENT (VARICEAL-B):
V - Vasoconstrictor therapy: (Octreotide 50mcg bolus
- Scoping Summary ... , consider for active ... acute settings - Pre-endoscopic ... #Summary #Endoscopy ... #algorithm #VARICEALB
Relapsing Acute Severe Ulcerative Colitis - Management Algorithm
Loss of Response:
 • (Re)consult Colorectal Surgery
 • Assess
Ulcerative Colitis - Management ... Response: • (Re ... Adherence • Assess Disease ... Activity: Flex ... #Algorithm #IBD
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Pott's Disease in ... Summary Epidemiology ... signs/symptoms of active ... pulmonary TB PE ... #Summary
Summary table of types of hypersensitivity reactions. 
Type 1
 - Mediators: lgE
 - Antigen Form: Soluble
Summary table of ... cell antigens, leading ... reaction, Haemolytic disease ... Antigen-antibody complexes are ... tissues where they activate
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Cardiomyopathy - Summary ... Valvular heart disease ... sx: dyspnea on exertion ... Period • Breast-feeding ... Avoid ARBs • ICD
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
terminal alveoli and are ... inhibitors • Injection ... involvement - seeding ... Langerhans giant cells are ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
terminal alveoli and are ... inhibitors • Injection ... involvement - seeding ... Langerhans giant cells are ... TB #Diagnosis #Management